| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | See Remarks
2 companies
Sinha Vikas is a Chief Financial Officer at SRRK, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 41 sales. Those positions are worth an estimated $31.2M at current prices.
Our model assigns Sinha Vikas a strong insider score of 84/100, based on 39 past trades. Over a 12-month horizon, 97.4% of those trades were profitable, with an average 12-month return of +60.5%.
Sinha Vikas's largest disclosed position is in SRRK as Chief Financial Officer, worth about $30.7M. The recent filings there lean toward selling, a net 27,165 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | SRRK Scholar Rock Holding Corporation | Chief Financial Officer | Sell | 10,410 | $49.57 | $516,070.55 | -1.7% | +8.1% | - | |
| Jan 13, 2026 | SRRK Scholar Rock Holding Corp | Chief Financial Officer | Sell | 16,755 | $42.70 | $715,438.50 | -2.8% | +13.2% | - | |
| Feb 21, 2025 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 303 | $10.08 | $3,052.97 | -0.6% | -70.6% | +3.8% | |
| Jan 23, 2025 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 129 | $9.50 | $1,225.86 | -0.3% | -31.2% | -3.8% | |
| Jan 10, 2025 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 979 | $0.44 | $430.86 | - | -27.6% | -3.2% | |
| Nov 19, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 3,186 | $0.55 | $1,747.52 | -0.3% | -25.6% | -48.1% | |
| Nov 5, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 5,136 | $0.86 | $4,442.13 | -0.4% | -57.0% | -78.0% | |
| Oct 22, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 3,428 | $0.77 | $2,649.33 | -0.3% | -47.6% | -75.5% | |
| Oct 3, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 940 | $0.81 | $765.91 | - | -45.0% | -64.7% | |
| Aug 19, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 3,159 | $0.76 | $2,399.26 | -0.3% | -24.6% | -85.4% |